Skip to content

Apotheek Van Daele Ann

Active
Private limited companyfounded 2011active for 15 yearsOude Dreef(NDW) 13, 2200 Herentals, BelgiumKBO/BCE: BE 0835.461.790

From the official registers: KBO 15 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

Apotheek Van Daele Ann has been active since 2011 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €225,638 and a net result of €53,329. Equity has been stable since 2018 (±2.5% per year). Its solvency ranks better than 52% of 12,757 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).

Overview

Official details

KBO
Status
Active since 11-04-2011 Normal situation
Legal form
Private limited company
Registered office
Oude Dreef(NDW) 13, 2200 Herentals
Activity
Retail sale of pharmaceutical products NACE 47730
Establishment unit
2.199.398.388 2270 Herenthout, since 11-04-2011
Financial year end
31 December
Peppol
Reachable since 31-10-2025

Board and ownership

Board

Financial position

89 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.2%
Annual accounts 2025
Gross margin
€209,886
▲ 88.5%
Turnover
≈ €980,000
estimated
Profit
€53,329
Equity
€225,638
▲ 15.8%
Total assets
€593,473
▼ 1.1%
Staff
1.2 FTE
=
2025 accounts filed 155 days before the deadline
Filed on 26-02-2026PDF
Score breakdownraises riskSector: Retail trade (NACE 47)lowers riskFounded in 2011Figures for financial year 2025 (filed on 26-02-2026)Size: 1.2 FTE, total assets €593,473Show the evidence

Checked score

Score 2025
89 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 54% of micro companies in retail trade (NACE 47)
Financial strength · tick: 2024
Average
Solvency 63+6
equity 38.0% of total assets
Liquidity 28-2
short-term debt 60.7% · cash 7.7%
Profitability 80+53
return on assets 9.0%
Bankruptcy probability within 12 months
0.2% Very low
0%0.5%1.5%4%10%≥ 25%

About 2 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,270 companies, NACE 47, micro)
Last 24 months 11-2024: 0.2%lowest value 12-2024: 0.2%● unchanged vs 11-2024lowest value 01-2025: 0.2%● unchanged vs 12-2024lowest value 02-2025: 0.2%● unchanged vs 01-2025lowest value 03-2025: 0.4%▲ +0.2 percentage points vs 02-2025 04-2025: 0.4%● unchanged vs 03-2025highest value 05-2025: 0.4%● unchanged vs 04-2025highest value 06-2025: 0.4%● unchanged vs 05-2025highest value 07-2025: 0.4%● unchanged vs 06-2025highest value 08-2025: 0.4%● unchanged vs 07-2025highest value 09-2025: 0.4%● unchanged vs 08-2025highest value 10-2025: 0.4%● unchanged vs 09-2025highest value 11-2025: 0.4%● unchanged vs 10-2025highest value 12-2025: 0.4%● unchanged vs 11-2025highest value 01-2026: 0.4%● unchanged vs 12-2025highest value 02-2026: 0.4%● unchanged vs 01-2026highest value 03-2026: 0.2%▼ -0.2 percentage points vs 02-2026 04-2026: 0.2%● unchanged vs 03-2026 05-2026: 0.2%● unchanged vs 04-2026 06-2026: 0.2%● unchanged vs 05-2026 07-2026: 0.2%● unchanged vs 06-2026 08-2026: 0.2%● unchanged vs 07-2026 09-2026: 0.2%● unchanged vs 08-2026 10-2026: 0.2%● unchanged vs 09-2026
Credit of up to €20,000 on 30-day terms is acceptable
Liquidity is tight, with a current ratio of 1.46 (1.52 in 2024), below the usual 1.5. Short-term debt is 60.7% and cash 7.7% of total assets. 62% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro). It does better than 53% of them on solvency, 25% on liquidity, 71% on profitability and 68% on growth.

The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskraises riskneutral
lowers risk · Founded in 2011
Companies that have existed this long fail less often. How much that weighs depends on the rest of the company's profile.
KBO
lowers risk · Figures for financial year 2025 (filed on 26-02-2026)
NBB · annual accounts
lowers risk · Size: 1.2 FTE, total assets €593,473
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
raises risk · Sector: Retail trade (NACE 47)
KBO
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 26-02-2026, 155 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
155 days early
2024
158 days early
2023
29 days early
2022
27 days early
2021
21 days early
2020
33 days early
2019
31 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 65 days before the deadline. In the sector (NACE 47), the median for financial year 2024 was on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 3 July (4 of the last 5 filed years within 127 days of that day).
Companies Code · seven months
Where today falls in the filing period
01-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Positive: Back in profit in 2025after a loss of €16,248 in 2024 €53,329 View
  • Positive: Filed on time since financial year 2018accounts within the deadline every year 8 years View

Documents

Annual accounts at the NBB

All 15 annual accounts

Articles and registers

Key facts about Apotheek Van Daele Ann

What is the company number of Apotheek Van Daele Ann?
The company number of Apotheek Van Daele Ann is 0835.461.790. The VAT number is the same number with BE in front: BE 0835.461.790.
Where is Apotheek Van Daele Ann based?
The registered office is at Oude Dreef(NDW) 13, 2200 Herentals.Company details
What does Apotheek Van Daele Ann do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of Apotheek Van Daele Ann?
The legal form of Apotheek Van Daele Ann is Private limited company (BV).
When was Apotheek Van Daele Ann founded?
Apotheek Van Daele Ann was founded on 11-04-2011.
Is Apotheek Van Daele Ann still active?
Yes, Apotheek Van Daele Ann is an active enterprise in the KBO register.
How many employees does Apotheek Van Daele Ann have?
Apotheek Van Daele Ann had an average of 1.2 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of Apotheek Van Daele Ann?
The turnover in financial year 2025 is ≈ €980,000. This figure is estimated from the gross margin of €209,886 and 51 comparable companies (NACE 477). It probably lies between €660,000 and €1.9m. In financial year 2021 turnover was €1.6m.
Is Apotheek Van Daele Ann profitable?
In financial year 2025, Apotheek Van Daele Ann made a profit of €53,329.
Where can I find the annual accounts of Apotheek Van Daele Ann?
Apotheek Van Daele Ann filed 15 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts 2025 (PDF)
When are the next annual accounts of Apotheek Van Daele Ann due?
Apotheek Van Daele Ann must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Comparable companies

These companies have the same main activity as Apotheek Van Daele Ann: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €465,000 and €650,000, founded between 2008 and 2014.

CompanyTotal assetsGross margin
Apotheek Van Daele Ann Herentals€593,473€209,886
APOTHEEK BODEN Essen€545,528€209,007
PHARMA 2424 Charleroi€550,405€195,539
APOTHEEK VOLLEZELE Pajottegem€577,422€206,097
FRENCKEN Antwerpen€464,818€232,117
Smith Pharma Willebroek€610,521€184,600
APOTHEEK VIRO Wervik€649,766€211,002
Full comparison

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.